Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial April 22, 2024 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:PSB Holdings, Inc. Reports First Quarter 2024 Earnings of $0.39 Per Share, Tangible Net Book Value Per Share Up 8% In Past Year Back: All Posts Next:Avangrid Featured on EARTH with John Holden to Kick off Earth Week